Cigna Announces CEO Succession and Leadership Transition Plan
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cigna ( (CI) ) has issued an announcement.
On February 25, 2026, The Cigna Group’s board approved a leadership transition under which long-serving chief executive David M. Cordani will retire as CEO on July 1, 2026 and become executive chair, while president and COO Brian C. Evanko, a nearly 30-year company veteran with broad operational and financial experience, will be promoted to CEO and join the board. The board also reshaped its leadership and committee structure and set new compensation packages for both executives, while reaffirming its full-year 2026 outlook for consolidated adjusted income from operations of at least $30.25 per share, including at least $6.9 billion from Evernorth and $4.5 billion from Cigna Healthcare, signaling confidence that the strategic and financial trajectory can be maintained through the succession.
The CEO succession marks a planned handover after nearly 17 years of Cordani’s leadership, during which Cigna evolved into a much larger, more diversified health company that emphasizes innovation in data, technology and AI-enabled services. By keeping Cordani as executive chair and elevating Evanko—who already oversees the company’s core business portfolio—the board aims to ensure continuity in strategy and governance at a time of rapid change in the health care sector, providing investors and other stakeholders with a measure of stability around growth and earnings expectations for 2026 despite the management shift.
The most recent analyst rating on (CI) stock is a Buy with a $370.00 price target. To see the full list of analyst forecasts on Cigna stock, see the CI Stock Forecast page.
Spark’s Take on CI Stock
According to Spark, TipRanks’ AI Analyst, CI is a Outperform.
The score is driven primarily by strong cash generation and improving 2025 fundamentals, supported by attractive valuation (low-teens P/E and a ~2%+ dividend). Earnings-call guidance is constructive but tempered by elevated medical cost trends and near-term cash flow/implementation risks from the PBM model transition, while technical signals are broadly neutral.
To see Spark’s full report on CI stock, click here.
More about Cigna
The Cigna Group is a global health company operating in the health insurance and health services industry through its Cigna Healthcare and Evernorth Health Services businesses. It provides medical benefits, pharmacy benefits management and related health services to about 180 million customer relationships worldwide, with a strategic focus on data, technology and AI to make care more personalized and affordable. Under outgoing CEO David M. Cordani, the company has transformed from a traditional insurer with $18 billion in annual revenue to a diversified health services group generating about $275 billion in annual revenue and delivering more than 750% total shareholder return.
Average Trading Volume: 1,658,311
Technical Sentiment Signal: Buy
Current Market Cap: $76.65B
For a thorough assessment of CI stock, go to TipRanks’ Stock Analysis page.
